Ledger.Open graph →
SEC Form D · Amendment · filed July 20, 2017

NEXEON MEDSYSTEMS INC

Offering
$2.0M
Sold
$1.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DALLAS, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Christopher R. Miller · DALLAS, TXExecKent J. George · LEXINGTON, KYDirectorWilliam M. Rosellini · LEXINGTON, KYExec · DirectorChristopher R. Miller · DALLAS, TXExecRonald M. Conquest · LEXINGTON, KYExec · DirectorBrian C. Blischak · LEXINGTON, KYExecDaniel P. Powell · DALLAS, TXExecKent J. George · LEXINGTON, KYDirectorMark C. Bates · ENCINITAS, CAExec · DirectorMichael J. Neitzel · LEXINGTON, KYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗